MARK A. LATINA
- Type
- Physician · Allopathic & Osteopathic Physicians / Ophthalmology
- Where
- READING, MA
- NPI
- 1801886346
- Received
- $279,035 in 944 records, 2019 to 2025 ($279,025 general, $10 research)
- As principal investigator
- $18,106 of research payments to others in 30 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 178 | $73,910 |
| 2024 | General payment | 180 | $48,973 |
| 2023 | General payment | 149 | $61,210 |
| 2022 | General payment | 143 | $49,212 |
| 2021 | General payment | 123 | $21,646 |
| 2020 | General payment | 69 | $3,777 |
| 2020 | Research payment | 1 | $10 |
| 2019 | General payment | 101 | $20,294 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 65 | $216,257 |
| Food and Beverage | 788 | $24,842 |
| Travel and Lodging | 74 | $22,941 |
| Consulting Fee | 7 | $8,900 |
| Compensation for serving as faculty or as a speaker for a medical education program | 3 | $6,000 |
| Gift | 1 | $45 |
| Education | 5 | $39 |
| Research payment | 1 | $10 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-23 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | XEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE | 2025 | |
| 2025-12-18 | Sight Sciences, Inc. | $149 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-12-17 | Tarsus Pharmaceuticals, Inc. | $35 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-12-17 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-12-15 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-12-09 | Alcon Vision LLC | $21 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-12-04 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-12-03 | Bausch & Lomb Americas Inc. | $16 | Food and Beverage | In-kind items and services | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-12-02 | Amgen Inc. | $19 | Food and Beverage | In-kind items and services | TEPEZZA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-12-02 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-11-24 | Glaukos Corporation | $29 | Food and Beverage | Cash or cash equivalent | iDoseTR Drug, Ophthalmology | 2025 | |
| 2025-11-19 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-11-18 | ABBVIE INC. | $725 | Consulting Fee | Cash or cash equivalent | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-11-18 | Thea Pharma Inc. | $18 | Food and Beverage | In-kind items and services | IYUZEH Drug, OPHTHALMOLOGY | 2025 | |
| 2025-11-17 | Lumibird Medical Inc. | $154 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-11-13 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-11-12 | ABBVIE INC. | $3,625 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-11-12 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | XEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE | 2025 | |
| 2025-11-11 | Alcon Vision LLC | $28 | Food and Beverage | In-kind items and services | TRYPTYR Drug, Ophthalmology | 2025 | |
| 2025-11-11 | Alcon Vision LLC | $6 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-11-10 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-11-05 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-11-05 | ABBVIE INC. | $27 | Travel and Lodging | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-11-05 | ABBVIE INC. | $25 | Travel and Lodging | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-11-04 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-10-30 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-10-29 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-10-28 | Alcon Vision LLC | $9 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-10-27 | ABBVIE INC. | $120 | Food and Beverage | In-kind items and services | XEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE | 2025 | |
| 2025-10-23 | Dompe US, Inc. | $107 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-10-23 | Thea Pharma Inc. | $24 | Food and Beverage | In-kind items and services | IYUZEH Drug, OPHTHALMOLOGY | 2025 | |
| 2025-10-23 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-10-19 | Sight Sciences, Inc. | $147 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-10-19 | Sight Sciences, Inc. | $142 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-10-19 | Alcon Vision LLC | $67 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-10-19 | Alcon Vision LLC | $41 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2025 | |
| 2025-10-19 | Sight Sciences, Inc. | $17 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-10-18 | ABBVIE INC. | $146 | Food and Beverage | In-kind items and services | XEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE | 2025 | |
| 2025-10-18 | Sight Sciences, Inc. | $131 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-10-18 | ABBVIE INC. | $36 | Food and Beverage | In-kind items and services | XEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE | 2025 | |
| 2025-10-16 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-10-15 | ABBVIE INC. | $3,625 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-10-15 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-10-14 | Dompe US, Inc. | $31 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-10-09 | Alcon Vision LLC | $6,045 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-10-09 | Alcon Vision LLC | $272 | Travel and Lodging | Cash or cash equivalent | Rhopressa Drug, Ophthalmology | 2025 | |
| 2025-10-09 | Alcon Vision LLC | $230 | Travel and Lodging | Cash or cash equivalent | Rhopressa Drug, Ophthalmology | 2025 | |
| 2025-10-09 | Alcon Vision LLC | $66 | Travel and Lodging | Cash or cash equivalent | Rhopressa Drug, Ophthalmology | 2025 | |
| 2025-10-09 | Alcon Vision LLC | $65 | Food and Beverage | Cash or cash equivalent | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-10-09 | Alcon Vision LLC | $56 | Travel and Lodging | Cash or cash equivalent | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-10-09 | Alcon Vision LLC | $55 | Travel and Lodging | Cash or cash equivalent | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-10-09 | Alcon Vision LLC | $49 | Travel and Lodging | Cash or cash equivalent | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-10-09 | Alcon Vision LLC | $30 | Travel and Lodging | Cash or cash equivalent | Rhopressa Drug, Ophthalmology | 2025 | |
| 2025-10-09 | Alcon Vision LLC | $30 | Travel and Lodging | Cash or cash equivalent | Rhopressa Drug, Ophthalmology | 2025 | |
| 2025-10-09 | Alcon Vision LLC | $28 | Food and Beverage | Cash or cash equivalent | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-10-09 | ANI Pharmaceuticals, Inc. | $23 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-10-09 | Alcon Vision LLC | $21 | Food and Beverage | Cash or cash equivalent | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-10-09 | Alcon Vision LLC | $19 | Food and Beverage | Cash or cash equivalent | Rhopressa Drug, Ophthalmology | 2025 | |
| 2025-10-09 | Alcon Vision LLC | $18 | Food and Beverage | Cash or cash equivalent | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-10-09 | Alcon Vision LLC | $6 | Food and Beverage | Cash or cash equivalent | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-10-09 | Alcon Vision LLC | $3 | Food and Beverage | Cash or cash equivalent | Rhopressa Drug, Ophthalmology | 2025 | |
| 2025-10-08 | ABBVIE INC. | $125 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-10-08 | ABBVIE INC. | $28 | Travel and Lodging | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-10-07 | Tarsus Pharmaceuticals, Inc. | $33 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-10-07 | Alcon Vision LLC | $6 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-09-23 | Alcon Vision LLC | $32 | Food and Beverage | In-kind items and services | TRYPTYR Drug, Ophthalmology | 2025 | |
| 2025-09-18 | Alcon Vision LLC | $6,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rhopressa Drug, Ophthalmology | 2025 | |
| 2025-09-18 | Alcon Vision LLC | $6,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-09-11 | Alcon Vision LLC | $1,016 | Travel and Lodging | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-09-11 | Alcon Vision LLC | $146 | Travel and Lodging | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-09-11 | Alcon Vision LLC | $121 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-09-10 | Alcon Vision LLC | $143 | Travel and Lodging | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-09-10 | Alcon Vision LLC | $97 | Food and Beverage | In-kind items and services | Rhopressa Drug, Ophthalmology | 2025 | |
| 2025-09-09 | Alcon Vision LLC | $1,635 | Travel and Lodging | In-kind items and services | Rhopressa Drug, Ophthalmology | 2025 | |
| 2025-09-09 | Alcon Vision LLC | $1,269 | Travel and Lodging | In-kind items and services | Rhopressa Drug, Ophthalmology | 2025 | |
| 2025-09-09 | Alcon Vision LLC | $906 | Travel and Lodging | In-kind items and services | Rhopressa Drug, Ophthalmology | 2025 | |
| 2025-09-09 | Alcon Vision LLC | $309 | Travel and Lodging | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-09-09 | Alcon Vision LLC | $263 | Travel and Lodging | In-kind items and services | Rhopressa Drug, Ophthalmology | 2025 | |
| 2025-09-09 | Alcon Vision LLC | $125 | Food and Beverage | In-kind items and services | Rhopressa Drug, Ophthalmology | 2025 | |
| 2025-09-02 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-08-27 | Alcon Vision LLC | $32 | Food and Beverage | In-kind items and services | TRYPTYR Drug, Ophthalmology | 2025 | |
| 2025-08-27 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-08-26 | Alcon Vision LLC | $164 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-08-26 | Tarsus Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-08-21 | Bausch & Lomb Americas Inc. | $23 | Food and Beverage | In-kind items and services | VYZULTA Drug, Ophthalmology | 2025 | |
| 2025-08-21 | Alcon Vision LLC | $22 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-08-21 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-08-18 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-08-14 | ABBVIE INC. | $2,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-08-12 | Alcon Vision LLC | $16 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-08-12 | Alcon Vision LLC | $5 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-08-06 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-07-31 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-07-22 | Alcon Vision LLC | $17 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2025 | |
| 2025-07-10 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-07-08 | Tarsus Pharmaceuticals, Inc. | $37 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-07-08 | Alcon Vision LLC | $9 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-07-07 | Bausch & Lomb Americas Inc. | $23 | Food and Beverage | In-kind items and services | XIIDRA Drug, Ophthalmology | 2025 | |
| 2025-07-02 | ANI Pharmaceuticals, Inc. | $27 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-07-01 | Thea Pharma Inc. | $25 | Food and Beverage | In-kind items and services | IYUZEH Drug, OPHTHALMOLOGY | 2025 | |
| 2025-06-26 | Alcon Vision LLC | $29 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-06-26 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-06-25 | Regeneron Healthcare Solutions, Inc. | $119 | Food and Beverage | In-kind items and services | EYLEA HD Biological, OPHTHALMOLOGY | 2025 | |
| 2025-06-25 | Oyster Point Pharma, Inc. | $23 | Food and Beverage | In-kind items and services | TYRVAYA Drug, Dry eyes | 2025 | |
| 2025-06-23 | ABBVIE INC. | $3,625 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | XEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE | 2025 | |
| 2025-06-23 | RxSight Inc | $22 | Food and Beverage | In-kind items and services | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | 2025 | |
| 2025-06-11 | ABBVIE INC. | $120 | Food and Beverage | In-kind items and services | XEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE | 2025 | |
| 2025-06-11 | ABBVIE INC. | $25 | Travel and Lodging | In-kind items and services | XEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE | 2025 | |
| 2025-06-11 | Alcon Vision LLC | $25 | Food and Beverage | In-kind items and services | EYSUVIS Drug, Ophthalmology | 2025 | |
| 2025-06-11 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-06-06 | ABBVIE INC. | $3,625 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-06-05 | Alcon Vision LLC | $1,500 | Consulting Fee | Cash or cash equivalent | Rhopressa Drug, Ophthalmology | 2025 | |
| 2025-06-05 | Bausch & Lomb Americas Inc. | $21 | Food and Beverage | In-kind items and services | VYZULTA Drug, Ophthalmology | 2025 | |
| 2025-06-01 | ABBVIE INC. | $65 | Food and Beverage | In-kind items and services | XEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE | 2025 | |
| 2025-05-29 | Sight Sciences, Inc. | $131 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-05-28 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-05-22 | Alcon Vision LLC | $5,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rhopressa Drug, Ophthalmology | 2025 | |
| 2025-05-22 | ABBVIE INC. | $145 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-05-22 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-05-20 | ABBVIE INC. | $59 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-05-20 | Oyster Point Pharma, Inc. | $28 | Food and Beverage | In-kind items and services | TYRVAYA Drug, Dry eyes | 2025 | |
| 2025-05-20 | ABBVIE INC. | $10 | Travel and Lodging | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-05-15 | Sight Sciences, Inc. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-05-14 | Sight Sciences, Inc. | $149 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-05-14 | Sight Sciences, Inc. | $17 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-05-14 | Sight Sciences, Inc. | $15 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-05-13 | Alcon Vision LLC | $10 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-05-09 | Bausch & Lomb Americas Inc. | $23 | Food and Beverage | In-kind items and services | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-05-07 | Alcon Vision LLC | $128 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-05-07 | Mallinckrodt Hospital Products Inc. | $32 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-05-06 | Alcon Vision LLC | $22 | Food and Beverage | In-kind items and services | EYSUVIS Drug, Ophthalmology | 2025 | |
| 2025-05-01 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-05-01 | Sight Sciences, Inc. | $30 | Travel and Lodging | Cash or cash equivalent | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-05-01 | Sight Sciences, Inc. | $28 | Travel and Lodging | Cash or cash equivalent | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-04-28 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-04-23 | Sight Sciences, Inc. | $145 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-04-23 | ANI Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-04-22 | SUN PHARMACEUTICAL INDUSTRIES INC. | $31 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-04-22 | Alcon Vision LLC | $5 | Food and Beverage | In-kind items and services | EYSUVIS Drug, Ophthalmology | 2025 | |
| 2025-04-17 | Alcon Vision LLC | $1,738 | Travel and Lodging | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-04-15 | Alcon Vision LLC | $31 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-04-11 | ABBVIE INC. | $3,625 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-04-11 | ABBVIE INC. | $142 | Food and Beverage | In-kind items and services | XEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE | 2025 | |
| 2025-04-09 | Sight Sciences, Inc. | $3 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-04-08 | ABBVIE INC. | $100 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-04-04 | Alcon Vision LLC | $176 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2025 | |
| 2025-04-03 | Sight Sciences, Inc. | $4,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-04-01 | Tarsus Pharmaceuticals, Inc. | $38 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-03-31 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-03-20 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-03-18 | ABBVIE INC. | $126 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-03-18 | ABBVIE INC. | $48 | Travel and Lodging | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-03-11 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-03-06 | Alcon Vision LLC | $10 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2025 | |
| 2025-02-27 | Thea Pharma Inc. | $27 | Food and Beverage | In-kind items and services | IYUZEH Drug, OPHTHALMOLOGY | 2025 | |
| 2025-02-26 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-02-25 | ANI Pharmaceuticals, Inc. | $30 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-02-21 | Bausch & Lomb Americas Inc. | $8 | Food and Beverage | In-kind items and services | VYZULTA Drug, Ophthalmology | 2025 | |
| 2025-02-21 | Bausch & Lomb Americas Inc. | $8 | Food and Beverage | In-kind items and services | VYZULTA Drug, Ophthalmology | 2025 | |
| 2025-02-20 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-02-18 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-02-18 | Bausch & Lomb Americas Inc. | $21 | Food and Beverage | In-kind items and services | XIIDRA Drug, Ophthalmology | 2025 | |
| 2025-02-14 | Sight Sciences, Inc. | $139 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-02-13 | Sight Sciences, Inc. | $27 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-02-11 | Alcon Vision LLC | $26 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-01-28 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-01-27 | Alcon Vision LLC | $11 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-01-24 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-01-23 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-01-22 | Tarsus Pharmaceuticals, Inc. | $120 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-01-16 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-01-15 | Amgen Inc. | $24 | Food and Beverage | In-kind items and services | TEPEZZA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-01-15 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-01-10 | ABBVIE INC. | $3,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | XEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE | 2025 | |
| 2025-01-08 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-01-07 | ABBVIE INC. | $740 | Travel and Lodging | In-kind items and services | XEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE | 2025 | |
| 2025-01-07 | ABBVIE INC. | $113 | Food and Beverage | In-kind items and services | XEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE | 2025 | |
| 2025-01-07 | Tarsus Pharmaceuticals, Inc. | $32 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2024-12-18 | Bausch & Lomb Americas Inc. | $20 | Food and Beverage | In-kind items and services | VYZULTA Drug, Ophthalmology | 2024 | |
| 2024-12-17 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2024 | |
| 2024-12-09 | BIOTISSUE HOLDINGS INC. | $24 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-12-09 | Sight Sciences, Inc. | $6 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2024 | |
| 2024-12-05 | Mallinckrodt Hospital Products Inc. | $31 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2024 | |
| 2024-12-04 | ABBVIE INC. | $725 | Consulting Fee | Cash or cash equivalent | DURYSTA Drug, EYE CARE | 2024 | |
| 2024-11-26 | BIOTISSUE HOLDINGS INC. | $24 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-11-21 | Bausch & Lomb Americas Inc. | $24 | Food and Beverage | In-kind items and services | XIIDRA Drug, Ophthalmology | 2024 | |
| 2024-11-19 | Tarsus Pharmaceuticals, Inc. | $28 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2024 | |
| 2024-11-14 | Alimera Sciences, Inc. | $21 | Food and Beverage | In-kind items and services | YUTIQ Drug, Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | 2024 | |
| 2024-11-13 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2024 | |
| 2024-11-12 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2024 | |
| 2024-11-08 | ABBVIE INC. | $3,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DURYSTA Drug, EYE CARE | 2024 | |
| 2024-11-07 | Sight Sciences, Inc. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2024 | |
| 2024-11-05 | Alcon Vision LLC | $25 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2024 | |
| 2024-11-05 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2024 | |
| 2024-10-30 | ABBVIE INC. | $118 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2024 | |
| 2024-10-30 | ABBVIE INC. | $30 | Travel and Lodging | In-kind items and services | DURYSTA Drug, EYE CARE | 2024 | |
| 2024-10-30 | ABBVIE INC. | $20 | Travel and Lodging | In-kind items and services | DURYSTA Drug, EYE CARE | 2024 | |
| 2024-10-30 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2024 | |
| 2024-10-29 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2024 | |
| 2024-10-25 | ABBVIE INC. | $3,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | XEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE | 2024 |
The latest 200 records of 944.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2020-12-31 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS-1000081017 | $2,328 | A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hyperte | 2020 |
| 2020-11-18 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS-1000081017 | $505 | XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS) | 2020 |
| 2020-10-29 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $40 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2020 |
| 2020-08-25 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $785 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2020 |
| 2020-08-19 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS-1000081017 | $305 | XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS) | 2020 |
| 2020-07-07 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $407 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2020 |
| 2020-07-07 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $80 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2020 |
| 2020-05-21 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS-1000081017 | $345 | XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS) | 2020 |
| 2020-05-07 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $75 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2020 |
| 2020-04-28 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $40 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2020 |
| 2020-04-23 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $304 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2020 |
| 2020-04-14 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $40 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2020 |
| 2020-03-31 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $120 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2020 |
| 2020-03-17 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS-1000081017 | $1,455 | XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS) | 2020 |
| 2020-03-10 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $487 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2020 |
| 2020-03-02 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS-1000081017 | $690 | XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS) | 2020 |
| 2020-02-18 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $40 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2020 |
| 2020-01-30 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $40 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2020 |
| 2020-01-23 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $40 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2020 |
| 2020-01-23 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $120 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2020 |
| 2020-01-23 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $80 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2020 |
| 2019-12-31 | Allergan, Inc. | MARK A LATINA MD LLC DBA ADVANCED GLAUCOMA SPECIAL | $945 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2019 |
| 2019-12-12 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $40 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2019 |
| 2019-12-05 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $407 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2019 |
| 2019-12-04 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS-1000081017 | $2,395 | XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma Gold-Standard Pathway Study GPS | 2019 |
| 2019-10-24 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $120 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2019 |
| 2019-10-24 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $670 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2019 |
| 2019-10-24 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $75 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2019 |
| 2019-10-10 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS | $447 | A COMPARISON OF BIMATOPROST SR TO SELECTIVE LASER TRABECULOPLASTY IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTE | 2019 |
| 2019-09-20 | Allergan, Inc. | ADVANCED GLAUCOMA SPECIALISTS-1000081017 | $4,680 | XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma Gold-Standard Pathway Study GPS | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Reading, MA, county Middlesex County, MA, state Massachusetts; placed by its city name.
| Measure | Place (city or town) Reading, MA | County Middlesex County, MA | State Massachusetts |
|---|---|---|---|
| Population B01003 | 25,612 | 1,638,365 | 7,044,056 |
| Population, 2020 census P1 | 25,518 | 1,632,002 | 7,029,917 |
| Median age B01002 | 43.7 | 38.9 | 40.0 |
| Under 18 B01001 | 22.8% | 19.5% | 19.4% |
| 65 and over B01001 | 20.7% | 16.3% | 17.9% |
| Households B11001 | 9,740 | 634,215 | 2,785,042 |
| Foreign born B05002 | 9.5% | 23.1% | 18.0% |
| Median household income B19013 | $165,912 | $130,847 | $103,960 |
| Median family income B19113 | $203,536 | $166,449 | $131,675 |
| Per capita income B19301 | $74,991 | $69,556 | $57,897 |
| Poverty rate B17001 | 3.2% | 7.7% | 10.0% |
| Unemployment rate B23025 | 3.3% | 4.4% | 5.2% |
| Civilian labor force B23025 | 13,754 | 946,989 | 3,911,446 |
| Mean commute (minutes) B08013 | 30.9 | 29.9 | 29.1 |
| Bachelor's degree or higher B15003 | 66.3% | 59.5% | 47.3% |
| Housing units B25001 | 9,951 | 664,267 | 3,030,406 |
| Owner-occupied B25003 | 82.4% | 61.3% | 62.5% |
| Renters B25003 | 17.6% | 38.7% | 37.5% |
| Median home value B25077 | $809,000 | $727,800 | $562,100 |
| Median gross rent B25064 | $1,991 | $2,201 | $1,762 |
| White, not Hispanic B03002 | 84.3% | 65.1% | 66.6% |
| Black B03002 | 0.5% | 4.7% | 6.4% |
| Hispanic or Latino B03002 | 5.6% | 9.3% | 13.3% |
| Asian B03002 | 6.3% | 13.6% | 7.3% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Economy now FRED unemployment 4.3% in Sep 2026 (4.6% a year earlier); per capita personal income $98,700 in 2025, up 27% in five years (+2.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Reading, MA.
Comments